Centrus Energy posted Q2 2026 revenue of $176.1 million, up 14% from the previous year, driven by increased uranium sales and new contracts. The company signed a $900 million High-Assay, Low-Enriched Uranium (HALEU) enrichment contract with the U.S. Department of Energy, boosting its backlog to $4.5 billion. Despite a GAAP net income decline to $16.8 million, adjusted net income rose to $38.7 million, reflecting strong operational progress and strategic investments in uranium enrichment capacity expansions. Centrus plans to complete its first new centrifuge by year-end 2026 and increase hiring at its Ohio and Tennessee facilities, positioning itself to capitalize on growing demand for nuclear fuel.
Centrus Energy Corp. announced a public offering of 500,000 Class A common shares, pre-funded warrants for 2,005,513 shares, and common warrants for nearly 7 million shares, priced around $199.60 each, expected to raise approximately $500 million bef...
Centrus Energy Corp. announced a public offering of Class A common stock, pre-funded warrants, and common warrants to raise capital. The proceeds will be used for general corporate purposes, including technology investments, debt repayment, capital e...
Centrus Energy and Radiant have agreed on a multi-year contract for Centrus to supply high-assay, low-enriched uranium (HALEU) fuel to support Radiant's deployment of Kaleidos microreactors. This deal adds a domestic U.S. source of HALEU, crucial for...
Stocks of small modular reactor developers NuScale Power and Oklo rose sharply by 13% and 7% respectively, signaling renewed investor interest in the nuclear energy sector despite a broadly declining market. This rally comes without new company-speci...
